Drug-drug interactions<unk>  interacts with stavudine and zalcitabine by competing intracellularly for activation and results in inhibiting phosphorylation. There is also a known interaction with nephrotoxic or bone marrow suppressive agents (e.g. doxorubicin) which increases the risk of hematologic toxicity of zidovudine. Monitoring renal function and hematologic tests can be used to assess these potential interactions. Drug-food interactions Half lives of lamivudine and Zidovudine are not affected by food and absorption rates were slowed when taken with food but were not clinically significant, therefore,<unk>  may be taken with or without food.
Lamivudine/zidovudine
Lamivudine/tenofovir
Abacavir/lamivudine
Lamivudine/raltegravir
Doravirine/lamivudine/tenofovir
Dolutegravir/lamivudine
Lamivudine/nevirapine/zidovudine
Abacavir/lamivudine/zidovudine